Skip to content
healthcare.dev

Depakote

NDC 0074-7325, Divalproex Sodium, tablet, delayed release, from AbbVie Inc..

Product NDC
0074-7325
Status
Listed
Labeler
AbbVie Inc.
Dosage form
TABLET, DELAYED RELEASE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA018723
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0074-7325 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • DIVALPROEX SODIUM125 mg/1

Pharmacologic classes

Anti-epileptic Agent [EPC]; Decreased Central Nervous System Disorganized Electrical Activity [PE]; Mood Stabilizer [EPC]

Package NDCNDC-11Package
0074-7325-1300074732513100 TABLET, DELAYED RELEASE in 1 BOTTLE (0074-7325-13)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/08a65cf4-7749-4ceb-6895-8f4805e2b01f
  • NADAC price for package 00074732513

    GET /v1/drugs/nadac/00074732513

Use it

Look up 0074-7325 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0074-7325 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0074-7325. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.